Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly And Coã®çŸåšã®åžå ŽäŸ¡æ Œã¯ï¿¥186,129.89ã24æéã®ååŒé«ã¯ï¿¥2.1Bã§ãããã®è³ç£ã®æäŸ¡ç·é¡ã¯ãéå»24æéã§0.07%å€åããï¿¥165.78Tãšãªã£ãŠããŸãã
ããŒã¯ã³åãããEli Lilly And Coã¯ï¿¥186,601.67ã§ååŒãããŠãããããŒã¯ã³åãããæäŸ¡ç·é¡ã¯ï¿¥1.14Bã24æéã®ååŒé«ã¯ï¿¥552.61Mã§ãããã®ããŒã¯ã³åãããè³ç£ã¯ãéå»24æéã§-0.03%å€åããŸããã